S&P 500   4,522.46 (-1.19%)
DOW   34,469.17 (-0.49%)
QQQ   382.89 (-1.80%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
S&P 500   4,522.46 (-1.19%)
DOW   34,469.17 (-0.49%)
QQQ   382.89 (-1.80%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
S&P 500   4,522.46 (-1.19%)
DOW   34,469.17 (-0.49%)
QQQ   382.89 (-1.80%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
S&P 500   4,522.46 (-1.19%)
DOW   34,469.17 (-0.49%)
QQQ   382.89 (-1.80%)
AAPL   162.44 (-0.81%)
MSFT   323.10 (-1.94%)
FB   305.04 (-1.72%)
GOOGL   2,824.20 (-1.23%)
AMZN   3,395.56 (-1.22%)
TSLA   1,023.75 (-5.61%)
NVDA   306.15 (-4.70%)
BABA   112.16 (-8.07%)
NIO   32.75 (-9.53%)
CGC   10.11 (-2.41%)
AMD   143.05 (-5.06%)
GE   93.06 (-2.28%)
MU   82.50 (-0.46%)
T   23.37 (+1.39%)
F   19.41 (-2.32%)
DIS   146.05 (-0.78%)
PFE   53.75 (+1.34%)
AMC   28.22 (-6.80%)
ACB   5.93 (-3.42%)
BA   197.13 (-2.59%)
NYSE:RCUS

Arcus Biosciences Earnings Date, Estimates, & History

$44.09
-0.90 (-2.00%)
(As of 12/3/2021 11:32 AM ET)
Add
Compare
Today's Range
$43.53
$45.17
50-Day Range
$31.38
$48.47
52-Week Range
$22.36
$49.10
Volume
5,458 shs
Average Volume
579,829 shs
Market Capitalization
$3.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.94

Earnings Summary

Upcoming
Earnings Date
Feb. 23
Estimated

Actual EPS
(Nov. 8)
-$1.11
Beat By $0.02

Consensus EPS
(Nov. 8)
-$1.13

Last Year's Q4 EPS
(11/5/2020)
$0.03

Skip Charts & View Estimated and Actual Earnings Data

Arcus Biosciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Arcus Biosciences Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arcus Biosciences (NYSE:RCUS) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.76)($0.65)($0.71)
Q2 20213($0.91)($0.53)($0.77)
Q3 20213($1.17)$0.68($0.47)
Q4 20213($1.23)($1.09)($1.15)
FY 202111($4.07)($1.59)($3.09)
Q1 20222($1.27)$4.19$1.46
Q2 20222($1.34)$0.57($0.39)
Q3 20222($1.38)($0.32)($0.85)
Q4 20222($1.42)($1.14)($1.28)
FY 20228($5.41)$3.30($1.06)

RCUS Earnings Information

Arcus Biosciences last posted its earnings data on November 8th, 2021. The reported ($1.11) earnings per share for the quarter, beating the consensus estimate of ($1.13) by $0.02. The business had revenue of $9.46 million for the quarter, compared to the consensus estimate of $9.27 million. Arcus Biosciences has generated ($4.10) earnings per share over the last year (($4.10) diluted earnings per share). Earnings for Arcus Biosciences are expected to grow in the coming year, from ($4.39) to ($3.58) per share. Arcus Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 23rd, 2022 based off prior year's report dates.

Arcus Biosciences (NYSE:RCUS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/23/2022
(Estimated)
        
11/8/20219/30/2021($1.13)($1.11)+$0.02($1.11)$9.27 million$9.46 million
8/4/20216/30/2021($0.87)($1.09)($0.22)($1.09)$18.43 million$9.46 million  
5/4/20213/31/2021($0.86)($1.08)($0.22)($1.08)$18.80 million$9.46 million
2/23/202112/31/2020($0.74)($0.82)($0.08)($0.82)$15.35 million$9.49 million
11/5/20209/30/2020$0.28$0.03($0.25)$0.03$66.03 million$64.53 million  
8/6/2020Q2 2020($0.54)($0.93)($0.39)($0.93)$1.50 million$1.75 million
5/5/20203/31/2020($0.56)($0.63)($0.07)($0.63)$2.00 million$1.75 million
3/5/202012/31/2019($0.51)($0.38)+$0.13($0.38)$1.37 million$9.75 million
11/5/2019Q3($0.4860)($0.51)($0.0240)($0.51)$1.34 million$1.75 million
8/6/2019Q2 2019($0.40)($0.64)($0.24)($0.64)$4.54 million$1.75 million
5/2/2019Q1 2019($0.3450)($0.41)($0.0650)($0.41)$1.25 million$1.75 million
3/5/2019Q4 2018($0.42)($0.28)+$0.14($0.28)$1.60 million$1.56 million
11/8/2018Q3($0.3770)($0.25)+$0.1270($0.25)$1.40 million$4.29 million
8/6/2018Q2 2018($0.3970)($0.3180)+$0.0790($0.32)$1.30 million$1.25 million
5/9/2018Q1 2018($0.8770)($1.37)($0.4930)($1.37)$1.30 million$1.25 million
(Earnings results data provided by Zacks Investment Research)












Arcus Biosciences (NYSE:RCUS) Earnings Frequently Asked Questions

When is Arcus Biosciences's earnings date?

Arcus Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 23rd, 2022 based off last year's report dates. Learn more on RCUS's earnings history

Did Arcus Biosciences beat their earnings estimates last quarter?

In the previous quarter, Arcus Biosciences (NYSE:RCUS) reported ($1.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.13) by $0.02. Learn more on RCUS's earnings details

How much revenue does Arcus Biosciences generate each year?

Arcus Biosciences (NYSE:RCUS) has a recorded annual revenue of $77.52 million.

How much profit does Arcus Biosciences generate each year?

Arcus Biosciences (NYSE:RCUS) has a recorded net income of -$122.86 million. RCUS has generated -$4.10 earnings per share over the last four quarters.

What is Arcus Biosciences's EPS forecast for next year?

Arcus Biosciences's earnings are expected to grow from ($4.39) per share to ($3.58) per share in the next year.

This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.